Sun Pharma Advanced Research Company Limited has informed the Exchange about Board Meeting held on 08-Aug-2022 to consider financial statements for the period ended June 2022 and Fund raising
Please find enclosed herewith Statement of Unaudited Financial Results (Standalone) for the quarter ended June 30, 2022, duly approved and taken on record by the Board of Directors of the Company at their meeting held today i.e. on August 8, 2022. The ???Limited Review Report??? issued by P G Bhagwat LLP, Chartered Accountants, Pune, Auditors of the Company, with respect to the said results is also enclosed.
Gokul Refoils and Solvent Limited has informed the Exchange about Board Meeting held on 08-Aug-2022 to consider financial statements for the period ended June 2022
The Anup Engineering Limited has informed the Exchange about Investor Presentation
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 08-Aug-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%
City Union Bank Limited has informed the Exchange about Board Meeting held on 08-Aug-2022 to consider Unaudited financial results for the period ended June 2022
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
Agarwal Industrial Corporation Limited has informed the Exchange about Board Meeting held on 08-Aug-2022 to consider financial statements for the period ended June 2022
Summit Securities Limited has informed the Exchange about Board Meeting held on 08-Aug-2022 to consider financial statements for the period ended June 2022
Bhagiradha Chemicals & Industries Limited has informed the Exchange about Board Meeting held on 08-Aug-2022 to consider financial statements for the period ended June 2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
